ViroCell & AvenCell Collaborate on CAR-T for Blood Cancers
29 Jul 2025 //
BUSINESSWIRE
AvenCell bags $112M to flick `switchable` CAR-Ts in the clinic
22 Oct 2024 //
FIERCE BIOTECH
AvenCell Presents Data from CD123-Directed Universal CAR T Cell Therapy Program
12 Dec 2022 //
BUSINESSWIRE
AvenCell to Present New Data from Lead Universal CAR T Therapy
03 Nov 2022 //
BUSINESSWIRE